Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

72 - Predicting Response to Resensitization of Radioiodine Resistant Thyroid Cancer With Whole Exome Sequencing

Kirstie Lithgow, Helen Huang, Denise Chan,Moosa Khalil, Mike Bristow, Vincent Dinculescu,Markus Eszlinger,Vicky Parkins,Ralf Paschke

Canadian Journal of Diabetes（2019）

Cited 0|Views13
No score
Abstract
Inhibition of MAPK signalling can restore sensitivity to radioactive iodine (RI) in patients with radioiodine resistant thyroid cancer. Tramatenib has recently been used to resensitize RI resistant RAS positive or RAS and BRAF negative thyroid carcinomas.
More
Translated text
Key words
radioiodine resistant thyroid cancer,sequencing,whole exome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined